skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 151,859  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Material Type:
Article
Add to My Research

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

Journal of clinical oncology, 2019-12, Vol.37 (34), p.3212-3222 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00308 ;PMID: 31150315

Full text available

2
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Material Type:
Article
Add to My Research

Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer

Clinical cancer research, 2022-05, Vol.28 (10), p.2094-2109 [Peer Reviewed Journal]

2022 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-21-3570 ;PMID: 35262677

Full text available

3
Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
Material Type:
Article
Add to My Research

Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4), p.771-783 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-19-1145 ;PMID: 31843981

Full text available

4
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia
Material Type:
Article
Add to My Research

AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia

Clinical cancer research, 2020-12, Vol.26 (24), p.6535-6549 [Peer Reviewed Journal]

ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-0863

Full text available

5
Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers
Material Type:
Article
Add to My Research

Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers

Cancer research (Chicago, Ill.), 2021-05, Vol.81 (10), p.2600-2611 [Peer Reviewed Journal]

2021 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-20-2123 ;PMID: 33727227

Full text available

6
Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
Material Type:
Article
Add to My Research

Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2530-2542 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;ISSN: 1535-7163 ;EISSN: 1538-8514 ;DOI: 10.1158/1535-7163.mct-17-1104 ;PMID: 30232146

Full text available

7
Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Material Type:
Article
Add to My Research

Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance

Cancer immunology research, 2017-08, Vol.5 (8), p.695-709 [Peer Reviewed Journal]

2017 American Association for Cancer Research. ;ISSN: 2326-6066 ;EISSN: 2326-6074 ;DOI: 10.1158/2326-6066.cir-16-0400 ;PMID: 28733349

Full text available

8
Multicenter Trial of [ 18 F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685
Material Type:
Article
Add to My Research

Multicenter Trial of [ 18 F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685

Journal of clinical oncology, 2019-07, Vol.37 (20), p.1704-1712 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.18.01182 ;PMID: 30768363

Full text available

9
Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients
Material Type:
Article
Add to My Research

Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients

Journal of the National Cancer Institute. Monographs, 2019-08, Vol.2019 (53) [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 1052-6773 ;EISSN: 1745-6614 ;DOI: 10.1093/jncimonographs/lgz016 ;PMID: 31425600

Full text available

10
Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort
Material Type:
Article
Add to My Research

Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort

Journal of clinical oncology, 2019-12, Vol.37 (34), p.3310-3319 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00129 ;PMID: 31622130

Full text available

11
Abstract 1731 More Efficient Inhibition of Topoisomerase II Alpha with (1E,4E)-1,7-Bis(4-hydroxyphenyl)Hepta-1,4-Dien-3-One
Material Type:
Article
Add to My Research

Abstract 1731 More Efficient Inhibition of Topoisomerase II Alpha with (1E,4E)-1,7-Bis(4-hydroxyphenyl)Hepta-1,4-Dien-3-One

The Journal of biological chemistry, 2024-03, Vol.300 (3) [Peer Reviewed Journal]

2024 The American Society for Biochemistry and Molecular Biology, Inc. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1016/j.jbc.2024.106097

Full text available

12
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Material Type:
Article
Add to My Research

FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors

Clinical cancer research, 2019-07, Vol.25 (13), p.3753-3758 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-4070 ;PMID: 30787022

Full text available

13
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Material Type:
Article
Add to My Research

Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents

info:eu-repo/semantics/OpenAccess ;ISSN: 0732-183X ;EISSN: 1527-7755

Digital Resources/Online E-Resources

14
Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer
Material Type:
Article
Add to My Research

Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (11), p.2047-2056 [Peer Reviewed Journal]

2022 The Authors; Published by the American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-21-3503 ;PMID: 35320354

Full text available

15
Preclinical evaluation of the Hsp70 peptide tracer TPP-PEG24-DFO[89Zr] for tumor-specific PET/CT imaging
Material Type:
Article
Add to My Research

Preclinical evaluation of the Hsp70 peptide tracer TPP-PEG24-DFO[89Zr] for tumor-specific PET/CT imaging

Cancer research (Chicago, Ill.), 2018-11, Vol.78 (21), p.6268-6281 [Peer Reviewed Journal]

Copyright ©2018, American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-18-0707 ;PMID: 30228173

Full text available

16
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Material Type:
Article
Add to My Research

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Journal of clinical oncology, 2018-02, Vol.36 (5), p.446-453 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.4853 ;PMID: 29240541

Full text available

17
Trop-2 Promotes Prostate Cancer Metastasis By Modulating β1 Integrin Functions
Material Type:
Article
Add to My Research

Trop-2 Promotes Prostate Cancer Metastasis By Modulating β1 Integrin Functions

Cancer research (Chicago, Ill.), 2013-05, Vol.73 (10), p.3155-3167 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-12-3266 ;PMID: 23536555

Full text available

18
Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes
Material Type:
Article
Add to My Research

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

Clinical cancer research, 2019-08, Vol.25 (15), p.4592-4602 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-1538 ;PMID: 30824587

Full text available

19
The Critical Role of RNA m6A Methylation in Cancer
Material Type:
Article
Add to My Research

The Critical Role of RNA m6A Methylation in Cancer

Cancer research (Chicago, Ill.), 2019-04, Vol.79 (7), p.1285-1292 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-18-2965

Full text available

20
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110)
Material Type:
Article
Add to My Research

Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110)

Journal of clinical oncology, 2019-01, Vol.37 (1), p.22-32 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.18.00052 ;PMID: 30388045

Full text available

Results 1 - 20 of 151,859  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (142,714)

Refine My Results

Creation Date 

From To
  1. Before 1964  (106)
  2. 1964 To 1978  (325)
  3. 1979 To 1993  (4,519)
  4. 1994 To 2009  (36,949)
  5. After 2009  (110,009)
  6. More options open sub menu

Subject 

  1. Cancer Research  (147,777)
  2. Science & Technology  (131,584)
  3. Life Sciences & Biomedicine  (128,842)
  4. Oncology  (121,045)
  5. Humans  (96,989)
  6. Female  (51,552)
  7. Tumors  (40,391)
  8. Male  (39,379)
  9. Animals  (34,295)
  10. Biological And Medical Sciences  (33,513)
  11. Middle Aged  (32,666)
  12. Medical Sciences  (30,635)
  13. Cancer  (30,406)
  14. Aged  (27,341)
  15. Adult  (25,124)
  16. Medicine  (23,937)
  17. Medicine & Public Health  (21,701)
  18. Mice  (21,472)
  19. Cell Line, Tumor  (20,191)
  20. Biomedical And Life Sciences  (20,190)
  21. More options open sub menu

Language 

  1. English  (151,799)
  2. Japanese  (93,753)
  3. Norwegian  (64)
  4. Portuguese  (55)
  5. Russian  (37)
  6. Turkish  (32)
  7. German  (32)
  8. Chinese  (23)
  9. Spanish  (17)
  10. French  (9)
  11. Korean  (2)
  12. Finnish  (2)
  13. Serbian  (1)
  14. Arabic  (1)
  15. Polish  (1)
  16. Dutch  (1)
  17. Welsh  (1)
  18. Persian  (1)
  19. Danish  (1)
  20. More options open sub menu

Searching Remote Databases, Please Wait